Advertisement

Controversial Issues on β-Blocker Treatment: Has Metoprolol an Additive Effect to Conventional Medical Treatment in Heart Failure Due to Dilated Cardiomyopathy?

  • G. Sinagra
  • D. Gregori
  • A. Perkan
  • A. Di Lenarda
  • B. Pinamonti
  • F. Longaro
  • A. Poletti
  • D. Chersevani
  • S. Klugmann
  • F. Camerini
Conference paper

Abstract

Despite the introduction of ACE-inhibitors and the consequent improvement in prognosis, mortality rates in patients with heart failure remain high, ranging from 10% to 40% depending on severity [1, 2]. Thus additional therapies are required to reduce the morbidity and mortality associated with heart failure.

Keywords

Heart Failure NYHA Class Conventional Medical Treatment North Scandinavian Enalapril Survival Study Cooperative North Scandinavian Enalapril Survival 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    The CONSENSUS Trial Study Group (1987) Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). New Engl J Med 316:1429–1435CrossRefGoogle Scholar
  2. 2.
    The SOLVD Investigators (1991) Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure. New Engl J Med 325:293–302CrossRefGoogle Scholar
  3. 3.
    Waagstein F, Hjalmarson A, Varnauskas E, Wallentin I (1975) Effect of chronic betaadrenergic receptor blockade in congestive cardiomyopathy. Br Heart J 37:1022–1036PubMedCrossRefGoogle Scholar
  4. 4.
    Slatton ML, Eichhorn EJ (1996) Beta-blocker therapy for heart failure. Curr Op Cardiol 11:263–268CrossRefGoogle Scholar
  5. 5.
    Waagstein F, Bristow MR, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A (1993) Beneficial effect of metoprolol in idiopathic dilated cardiomyopathy. Lancet 342:1441–1446PubMedCrossRefGoogle Scholar
  6. 6.
    Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, Shusterman NH (1996) The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. New Engl J Med 334:1349–1357PubMedCrossRefGoogle Scholar
  7. 7.
    Australia New Zealand Heart Failure Research Collaborative Group (1997) Randomized, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet 349:375–380CrossRefGoogle Scholar
  8. 8.
    CIBIS Investigators and Committees (1994) A randomized trial of β-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study. Circulation 90:1765–1773Google Scholar
  9. 9.
    Heidenreich PA, Lee TT, Massie BM (1997) Effect of beta-blockade on mortality in patients with heart failure: a meta-analysis of randomized clinical trials. J Am Coll Cardiol 30:27–34PubMedCrossRefGoogle Scholar
  10. 10.
    Liang KY, Zeger SL (1986) Longitudinal data analysis using generalized linear models. Biometrika 73:13–22CrossRefGoogle Scholar
  11. 11.
    Zeger SL, Liang KY (1986) Longitudinal data analysis for discrete and continous outcomes. Biometrics 42:121–130PubMedCrossRefGoogle Scholar
  12. 12.
    Taesung Park (1993) A comparison of the generalized estimating equation approach with the maximum likelihood approach for repeated measurement. Statistics in Medicine 12:1723–1732CrossRefGoogle Scholar
  13. 13.
    Eichhorn EJ, Bristow MR (1996) Medical therapy can improve the biological properties of the chronically failing heart. A new era in the treatment of heart failure. Circulation 94:2285–2296Google Scholar
  14. 14.
    Di Lenarda A, Gregori D, Sinagra G, Lardieri G, Perkan A, Pinamonti B, Salvatore L, Secoli G, Zecchin M, Camerini F (1996) Metoprolol in dilated cardiomiopathy: is it possible to identify factors predictive of improvement? J Cardiac Failure 2:87–102CrossRefGoogle Scholar
  15. 15.
    Fitzmaurice GM, Laird NM, Rotnizky AG (1993) Regression models for discrete longitudinal responses. Statistical Science 8:284–309CrossRefGoogle Scholar
  16. 16.
    Hall SA, Cigarroa CG, Marcoux L, Risser RC, Grayburn PA, Eichhorn EJ (1995) Time course of improvement in left ventricular function, mass and geometry in patients with congestive heart failure treated with β-adrenergic blockade. J Am Coll Cardiol 25:1154–1161PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • G. Sinagra
  • D. Gregori
  • A. Perkan
  • A. Di Lenarda
  • B. Pinamonti
  • F. Longaro
  • A. Poletti
  • D. Chersevani
  • S. Klugmann
  • F. Camerini

There are no affiliations available

Personalised recommendations